Table 2. Angiographic parameters of the study population.
| NAFLD group (n=377) |
Control group (n=479) |
p | ||
|---|---|---|---|---|
| Indications for angiography Generally (%) |
||||
| Elective | 241 (63.9) | 271 (56.78) | 0.034 | |
| ACS | 136 (36.07) | 207 (43.21) | ||
| CCS angina | 93 (24.66) | 114 (23.79) | ||
| MPS positivity | 76 (20.15) | 74 (15.44) | ||
| Exercise test positivity | 72 (19.09) | 82 (16.70) | ||
| Low LVEF | 3 (0.79) | 6 (1.25) | ||
| Anterior MI | 19 (5.03) | 27 (5.63) | ||
| Inferior MI | 14 (3.71) | 22 (4.59) | ||
| Lateral MI | 1 (0.26) | 3 (0.62) | ||
| NSTEMI | 36 (9.54) | 46 (9.60) | ||
| USAP | 42 (11.14) | 47 (9.81) | ||
| Premature CAD (%) | 204 (54.11) | 204 (42.58) | <0.001 | |
| Coronary artery lesions (%) | ||||
| LMCA | 17 (4.50) | 25 (5.21) | 0.822 | |
| LAD | 185 (49.07) | 212 (44.25) | ||
| CX | 126 (33.42) | 144 (30.06) | ||
| RCA | 125 (33.10) | 156 (32.56) | ||
| SB | 95 (25.19) | 126 (26.30) | ||
| Coronary collateral flow (%) | ||||
| 0–1 | 349 (92.57) | 439 (91.64) | 0.856 | |
| 2 | 27 (7.16) | 39 (8.14) | ||
| 3 | 1 (0.26) | 1 (0.20) | ||
| Coronary ectasia (%) | 8 (2.12) | 7 (1.46) | 0.465 | |
| Coronary calcification (%) | 2 (0.53) | 2 (0.41) | 0.810 | |
| Coronary anomaly (%) | 4 (1.06) | 5 (1.04) | 0.983 | |
| Coronary slow flow (%) | ||||
| 0–1 | 4 (1.06) | 5 (1.04) | 0.825 | |
| 2 | 18 (4.77) | 23 (4.80) | ||
| 3 | 355 (94.16) | 451 (94.15) | ||
| LVEF (%) | 59 (54.5–61.5) | 57 (51–61) | 0.036 | |
NAFLD: nonalcoholic fatty liver disease; ACS: acute coronary syndrome; CCS: Canadian Cardiovascular Society; MPS: myocardial perfusion scintigraphy; LVEF: ejection fraction; MI: myocardial infarction; NSTEMI: non-ST-elevation myocardial infarction; USAP: unstable angina pectoris; CAD: coronary artery disease; LMCA: left main coronary artery; LAD: left anterior descending coronary artery; CX: circumflex coronary artery; RCA: right coronary artery; SB: side branch coronary artery.